Know Cancer

or
forgot password

New England School of Acupuncture (NESA) Acupuncture Research Collaborative


Phase 1
18 Years
N/A
Not Enrolling
Female
Ovarian Neoplasms, Endometriosis, Pelvic Pain, Uterine Neoplasms

Thank you

Trial Information

New England School of Acupuncture (NESA) Acupuncture Research Collaborative


This trial comprises three studies. In the first two studies, women will be randomly
assigned to receive either real or sham acupuncture therapy. Study 1 will include women with
various forms of cancer. White blood cell counts will be used to assess the effects of
acupuncture on participants' immune responses. Study 2 will include women with unspecified
pelvic pain and endometriosis; a self-report pain scale will be used to assess the effects
of acupuncture on participants' symptoms. Study 3 will evaluate the validity and reliability
of diagnoses made by Chinese medicine practitioners. In this study, a group of Chinese
medicine practitioners will diagnose the same group of patients; consistency of the
diagnoses will be evaluated.

Inclusion Criteria


Inclusion Criteria for Study 1:

- Newly diagnosed ovarian cancer; primary peritoneal cancer; papillary serous cancer of
the endometrium; or mixed mesodermal tumor of the uterus, ovary, or fallopian tube

- Currently undergoing chemotherapy

- Meet certain laboratory test requirements

Inclusion Criteria for Study 2:

Currently closed to recruitment

- Diagnosed with endometriosis or unspecified pelvic pain

Exclusion Criteria for Studies 1 and 2:

- Use of white blood cell boosters

- Prior radiotherapy with the exception of whole-breast irradiation for breast cancer

- Prior myelotoxic chemotherapy

- History of symptomatic cardiac or psychiatric disorder

- Use of a pacemaker

- Use of herbs or herbal supplements

- Prior use of acupuncture

- Enrollment in other research studies

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment

Principal Investigator

Peter Wayne, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

New England School of Acupuncture

Authority:

United States: Federal Government

Study ID:

U19 AT002022

NCT ID:

NCT00090389

Start Date:

January 2005

Completion Date:

May 2007

Related Keywords:

  • Ovarian Neoplasms
  • Endometriosis
  • Pelvic Pain
  • Uterine Neoplasms
  • Acupuncture
  • Medicine, Chinese Traditional
  • Neoplasms
  • Endometriosis
  • Ovarian Neoplasms
  • Pelvic Pain
  • Uterine Neoplasms

Name

Location

Dana Farber Cancer Institute Boston, Massachusetts  02115